BioSpace News Archive

Biotech Beach

Tocagen Added to NASDAQ Biotechnology Index

Tocagen today announced it has been selected for addition to the NASDAQ Biotechnology Index, which will become effective prior to the open of U.S. markets on Monday, December 18, 2017.

December 14, 2017

·

1 min read

Biotech Bay

Bay Area’s Bay Labs Completes $5.5M Series A Funding Round

The Series A round was led by existing investor Khosla Ventures with participation from new investors including Data Collective, Greenbox Venture Partners, Minneapolis Heart Institute Ventures and Georges Harik.

December 14, 2017

·

3 min read

Pharm Country

Precipio Files a Patent Application for IV-Cell, its Novel Cytogenetics Media

Commercialization plans include third-party validation of the media, alongside discussions with potential industry players to acquire product rights and associated IP.

December 14, 2017

·

6 min read

Strongbridge Biopharma plc Announces New Employment Inducement Awards - Dec. 14, 2017

The inducement awards are being made in the form of non-qualified stock options to purchase an aggregate of 391,650 ordinary shares of the Company.

December 14, 2017

·

3 min read

Business

Matinas BioPharma Appoints Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A., to Board of Directors

Dr. Wikler will replace current Board member, Stefano Ferrari, effective January 1, 2018.

December 14, 2017

·

6 min read

Business

Allena Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

As of September 30, 2017, cash and cash equivalents were $33.9 million, as compared to cash, cash equivalents and short-term investments of $48.8 million as of December 31, 2016.

December 14, 2017

·

9 min read

Business

Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.

The licensing agreement is for a term of seven years with extensions to the term available.

December 14, 2017

·

4 min read

Business

Jaguar Health and Dubai-based Seed Mena Enter Collaboration Agreement for Equilevia, Jaguar’s Personalized, Premium Product for Total Gut Health and Wellness in Horses

According to the terms of the Agreement, Jaguar will pay SEED an ongoing percentage of revenue generated from any clients or partners introduced to Jaguar by SEED, and the agreed-upon revenue percentage increases after the first one-million dollars of revenue.

December 14, 2017

·

6 min read

Genetown

IDBS Adds Synthetic Chemistry to its E-WorkBook Connect Platform

IDBS has extended its E-WorkBook Connect cloud-based platform to include a synthetic chemistry offering.

December 14, 2017

·

1 min read

Drug Development

Cellectar Files IND for Phase I Trial of CLR 131 in Pediatric Cancers

The study will be initiated with the pediatric oncologists and Nuclear Medicine/Radiology Group at The University of Wisconsin Carbone Cancer Center.

December 14, 2017

·

6 min read